Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from SPAC

A list is out breaking down the top billionaires around the world, and one former president might be excited to see the results.

Benzinga

Is Ginkgo Bioworks a Buy Under $5?

Cell programming platform operator Ginkgo Bioworks (DNA) went public late last year in an SPAC merger. Since then, the stock has plummeted more than 60% in price, closing yesterday’s session at $4.13. In addition, analysts have increased their loss per share expectations for the stock for this year. So, would…

StockNews.com

Is Trump's Truth Social Already Doomed? Why Elon Musk Could Put The Final Nail In The Coffin

A leading social media platform could find itself in the middle of a hot debate that could divide the country. The potential move could also increase the slow demise of a social media platform created by a former president.

Benzinga

From analysis to the latest developments in health,
read the most diverse news in one place.

Taiwanese scooter brand Gogoro makes Nasdaq debut in rare IPO

Electric scooter maker is just the third Taiwanese firm to go public in the US in the past five years.

Al Jazeera

Merger Arbitrage Mondays - Nielsen Holdings To Be Taken Private By A Consortium Of Private Equity Firms

Merger activity increased significantly last week with six new deals announced and eight deals completed. There were 17 deals announced in the month of March, with a total value of $64.55 billion. Nielsen Holdings (NYSE: NLSN)

Benzinga

U.S.-Bound China IPO Train Could Resume by Summer, Latest Signals Show

Key Takeaways:

Benzinga

Hypebeast SPAC: Inside The Hong Kong Company Tom Brady, Kevin Durant And Others Are Investing In

A SPAC merger agreement announced Monday brought some additional fanfare with several notable athletes and celebrities among the investors in the company’s PIPE. Here’s a look at the company and deal.

Benzinga

Read news from The Economist, FT, and more,
with one subscription

InterCure Reports Record FY 2021 Revenue Of $89M, Q4 Adjusted EBITDA Spikes 140% YoY

InterCure Ltd. (NASDAQ: INCR) (TSX: INCR.U) (TASE: INCR), which is doing business as Canndoc, has announced its estimated financial and operating results for the fourth quarter and year ended December 31, 2021.

Benzinga

Electric vehicle start-ups face their toughest challenge: making cars

Investors have bet heavily hoping to find the next Tesla, but many EV groups are struggling to make the production process work

Financial Times

Trump's social media app misses another deadline as users report issues

Tech issues are likely at fault, sources tell Axios.

Axios

Faux News Alert: Elon Musk Arrested, Queen Grabs Oligarch Yachts And Other April Fool's Antics

T.S. Eliot once opined that April was the cruelest month, and for the gullible among us, April 1 is the cruelest day of that month — especially if you fall for the off-kilter fake news stories permeating the internet on this day.

Benzinga

Global Dealmaking Drops To Lowest Level Since Onset Of Pandemic: FT

Global dealmaking fell to its lowest level since the coronavirus pandemic as surging inflation, stricter regulation, and the war in Ukraine led to a slowdown in what had been a record period of mergers and acquisitions,

Benzinga

SEC Proposes For Greater Disclosures From Blank-Cheque Company Sponsors: FT

Wall Street's watchdog on Wednesday unveiled a draft new rule to enhance blank-check or special purpose acquisition company (SPAC) investor disclosures and to strip them of legal protection critics argue has allowed the sh

Benzinga

Truth Social App Downloads Dropping: Will It Hurt The Trump SPAC Price?

A social media platform from former President Donald Trump was launched with a ton of hype and saw strong downloads initially. A new report shows interest could be waning, which could impact a SPAC.

Benzinga

Get all your
news in one place.

100's of premium titles.
One news app.

Axios

SEC votes in favor of rules to crack down on SPACs

SPACs would be subject to the same restrictions on forward-looking statements as are IPOs.

Benzinga

OnlyFans Explores SPAC Merger, Could Be Going Public: What You Need To Know

Social media platform OnlyFans could become the latest company to go public to continue its impressive growth. One element of the company’s business could be keeping investors from getting excited about the company and prevent a SPAC merger.

Input

OnlyFans could ban porn again in its push for an IPO

Amateur pornography is what made OnlyFans big at all — but money talks.

Axios

Scoop: OnlyFans wants to go public through a SPAC

The social media company, known for its adult content, is talking to SPACs.

Get all your
news in one place.

100's of premium titles.
One news app.

StockNews.com

Fast Radius: Should You Scoop Up Shares of the Beaten Down Software Stock?

Additive manufacturing solutions company Fast Radius (FSRD) made its market debut last month through an SPAC merger. However, the stock has since declined more than 65% in price. Also, given current market volatility, would it be wise to invest in the stock now? Continue reading to learn our view.

Benzinga

Merger Arbitrage Mondays - Berkshire Hathaway Acquires Insurer Alleghany For $11.6 Billion

Merger activity decreased last week with three new deals announced and two deals completed. Alleghany Corporation (NYSE: Y)

Benzinga

China Offers Up Luxury Investment With Lanvin Backdoor Listing Plan

Key Takeaways:

Benzinga

What The Covfefe Is Going On With Digital World Stock?

Digital World Acquisition Corp (NASDAQ: DWAC), the SPAC merging with Trump Media & Technology Group, was trading slightly higher on Thursday in a strong uptrend. An uptrend occurs when a stock consistently makes a series of higher highs and higher lows on the chart.

Benzinga

The Daily Biotech Pulse: Novartis Prostate Cancer Drug Lands FDA Approval, Ligand Announces SPAC Deal To Spin Off Antibody Business, Lilly's Lung Cancer Therapy Hit With CRL

Here's a roundup of top developments in the biotech space over the last 24 hours:

Benzinga

Ligand To Spin-Off OmniAb Via Avista Capital-Backed SPAC Merger

Ligand Pharmaceuticals Inc (NASDAQ: LGND)

Benzinga

Why Allego Shares Are Surging

Allego NV (NYSE: ALLG) shares are trading significantly higher Wednesday after the company announced the completion of its SPAC merger agreement with Spartan Acquisition Corp, which resulted in 98% of the company notes being redeemed at the merger vote.

1 … 11 12 13 14

People

Marjorie Taylor Greene

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.